drugset / Trial / NCT00003464

Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme

NCT00003464 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating adults with newly diagnosed primary malignant glioblastoma multiforme.

Timeline

Start
1997-09
Primary completion
—
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral